top
Search terms
Results 1 - 7 of 7 - ordered by :
Ehjcvp

Proton pump inhibitor use by aspirin-treated coronary artery disease patients is not associated with increased risk of cardiovascular events Introduction Cardiovascular disease (CVD) is widespread, ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLES, Laura A. Fortuna, Pamala A. Pawloski, Emily D. Parker, Nicole K. Trower, Thomas E. Kottke

Date : 01/01/2016 Item size : 263457 bytes
Ehjcvp

Optimal handling of the healthy In the preventive section, the HOPE-3 (Heart Outcomes Prevention Evaluation 3) trial stole the limelight, first and foremost by strengthening faith in statinsthis time ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Manan Pareek, Deepak L. Bhatt

Date : 01/07/2016 Item size : 164372 bytes
Ehjcvp

[...]year of a journal Since they are selected due to their known knowledge and good reputation, my friends expected that their fees would be sky high. Laura Fortuna and co-workers from USA ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Stefan Agewall

Date : 01/01/2016 Item size : 108210 bytes
Ehjcvp

ApoA-I Milano (apoA-IM) is a natural variant of human apoA-I identified in individuals in northern Italy, which results from the replacement of arginine by cysteine at position 173 of the apoA-I ...

European Heart Journal - Cardiovascular Pharmacotherapy, INVITED EDITORIAL, Antonio J. Vallejo-Vaz, Kausik K. Ray

Date : 01/01/2016 Item size : 167390 bytes
Ehjcvp

Unfortunately, gastrointestinal bleeding in patients after acute coronary syndrome portends poor prognosis and is independently associated with increased risk for adverse cardiovascular events and ...

European Heart Journal - Cardiovascular Pharmacotherapy, INVITED EDITORIAL, Muthiah Vaduganathan, Deepak L. Bhatt

Date : 01/01/2016 Item size : 163944 bytes
Ehjcvp

In recent years, guidance from both the US Food and Drug Administration (FDA)2 and the European Medicines Agency (EMA)3 addressing evaluation of the cardiovascular risk of new antidiabetic drugs for ...

European Heart Journal - Cardiovascular Pharmacotherapy, Editorials, J. Rick Turner, Dilip R. Karnad, Snehal Kothari, Alan Metz, Hitesh Patel, Erica Caveney

Date : 01/01/2017 Item size : 128050 bytes
Ehjcvp

Effects of reninangiotensinaldosterone system blockade on cardiovascular system The benefits of blocking the RAAS in heart failure (HF) and post-myocardial infarction (MI) were largely proved many ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEW, Gema Ruiz-Hurtado, Luis Miguel Ruilope

Date : 01/04/2015